Cormorant Asset Management, LP - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$32,445,000
+109083.6%
5,150,0000.0%1.82%
-7.2%
Q1 2023$29,716
-43.8%
5,150,0000.0%1.96%
-44.7%
Q4 2022$52,839
-99.9%
5,150,000
+3.0%
3.54%
-39.5%
Q3 2022$83,600,000
+8.6%
5,000,000
-9.1%
5.84%
+0.4%
Q2 2022$77,000,000
-7.5%
5,500,000
+6.7%
5.82%
-8.9%
Q1 2022$83,285,000
-28.5%
5,156,994
-5.2%
6.39%
-7.7%
Q4 2021$116,480,000
+47.8%
5,440,453
+1.4%
6.93%
+116.4%
Q3 2021$78,810,000
-25.6%
5,364,850
-0.9%
3.20%
-11.1%
Q2 2021$105,965,000
-27.6%
5,414,850
+5.9%
3.60%
+10.4%
Q1 2021$146,409,0005,114,8503.26%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders